MedTrace Logo

Understanding Lung Cancer Related Risk Factors and Their Impact

NCT06473870 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 6160

Last updated 2024-06-25

No results posted yet for this study

Summary

LUCIA aims to develop prediction models for the early diagnosis of lung cancer based on the identification of risk factors and deeper cellular knowledge, by recording real-world data; with risk assessment tools, non-invasive devices and omics analysis. These models will enable new clinical pathways and diagnostic workflow to be implemented to ensure early diagnosis and confirmation, including classification of lung cancer subtype.

Conditions

  • Lung Cancer Screening

Sponsors & Collaborators

  • Technion, Israel Institute of Technology

    collaborator OTHER

  • Centro Nacional de Análisis Genómico

    collaborator UNKNOWN

  • Vicomtech

    collaborator UNKNOWN

  • University of Latvia

    collaborator OTHER

  • Centre Hospitalier Universitaire de Liege

    collaborator OTHER

  • Andaluz Health Service

    collaborator OTHER_GOV

  • Nanose Medical Ltd.

    collaborator INDUSTRY

  • Biocruces Bizkaia Health Research Institute

    lead OTHER_GOV

Principal Investigators

  • Luis G Luque-Romero, MD · Andaluz Health Service

  • David Vicente-Baz, MD · Andaluz Health Service

  • Alvils Krams, MD · University of Latvia

  • Julien Guiot, MD · Centre Hospitalier Universitaire de Liege

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Belgium
  • Latvia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06473870 on ClinicalTrials.gov